Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Unity Biotechnology Inc (UBX)
NASDAQ:UBX
Unity Biotechnology (UBX) Stock Price & Analysis
687 Followers
UBX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.46 - $3.82
Previous Close$1.48
Volume112.61K
Average Volume (3M)85.46K
Market Cap
$24.85M
Enterprise Value$3.34M
Total Cash (Recent Filing)$45.94M
Total Debt (Recent Filing)$24.43M
Price to Earnings (P/E)-0.6
Beta1.20
Next Earnings
Aug 06, 2024EPS Estimate
-$0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.51
Shares Outstanding16,789,577
10 Day Avg. Volume56,473
30 Day Avg. Volume85,459
Standard Deviation0.23
R-Squared0.04
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.69
Price to Sales (P/S)105.29
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.80
Enterprise Value/Gross Profit14.15
Enterprise Value/Ebitda-0.07
Forecast
1Y Price Target
$8.00Price Target Upside463.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Unity Biotechnology News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
UBX FAQ
What was Unity Biotechnology Inc’s price range in the past 12 months?
Unity Biotechnology Inc lowest stock price was $1.46 and its highest was $3.82 in the past 12 months.
What is Unity Biotechnology Inc’s market cap?
Currently, no data Available
When is Unity Biotechnology Inc’s upcoming earnings report date?
Unity Biotechnology Inc’s upcoming earnings report date is Aug 06, 2024 which is in 77 days.
How were Unity Biotechnology Inc’s earnings last quarter?
Currently, no data Available
Is Unity Biotechnology Inc overvalued?
According to Wall Street analysts Unity Biotechnology Inc’s price is currently Undervalued.
Does Unity Biotechnology Inc pay dividends?
Unity Biotechnology Inc does not currently pay dividends.
What is Unity Biotechnology Inc’s EPS estimate?
Unity Biotechnology Inc’s EPS estimate is -$0.48.
How many shares outstanding does Unity Biotechnology Inc have?
Unity Biotechnology Inc has 16,789,577 shares outstanding.
What happened to Unity Biotechnology Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Unity Biotechnology Inc?
Among the largest hedge funds holding Unity Biotechnology Inc’s share is Invus Financial Advisors, LLC. It holds Unity Biotechnology Inc’s shares valued at N/A.
---
Unity Biotechnology Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (463.38% Upside)
$8.00 (463.38% Upside)
Blogger Sentiment
Bullish
UBX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 109.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.57%
12-Months-Change
Fundamentals
Return on Equity
-91.08%
Trailing 12-Months
Asset Growth
-48.48%
Trailing 12-Months
Company Description
Unity Biotechnology Inc
Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel David, Jan van Deursen, Judith Campisi and Daohong Zhou in March 2009 and is headquartered in Brisbane, CA.
---
UBX Stock 12 Month Forecast
Average Price Target
$8.00
▲(463.38% Upside)
Technical Analysis
Best Analysts Covering UBX
1 Year
1 Year Success Rate
3/15 ratings generated profit
1 Year Average Return
-34.49%
upgraded a buy rating 6 months ago
Copying Andreas Argyrides's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -34.49% per trade.
---